Organic growth · 25. June 2018
Pour faire face à une demande grandissante et afin d’accélérer sa croissance, SYnAbs cherche aujourd’hui à élargir son équipe avec de nouveaux employés à fort potentiel. SYnAbs est une société d’innovation en biotechnologie qui a développé une expertise dans la génération d’anticorps monoclonaux uniques à partir des espèces animales de rat et de cochon d’Inde. Née à la fin 2015, et fort d’une expérience éprouvée en culture cellulaire et purification, SYnAbs a...
Congress · 19. June 2018
SYnAbs was present in Oxford, UK, attending the 10th anniversary of Pivotal Scientific team!

Congress · 06. February 2018
SYnAbs has presented its one-stop-shop offer in CAR-T from CAR design to anti-ScFv generation!
Congress · 01. February 2018
SYnAbs attended Innovation for Health congress in Rotterdam, Netherlands to promote custom mAb generation services in rat and guinea pig species to obtain monoclonal antibodies of higher affinity and better specificity against difficult targets

Technical breakthrough · 24. January 2018
Want to discriminate class and subclass isotype of your mAb in a fast and efficient way? Choose SYnAbs mouse isotyping kit!
Distribution agreement · 24. January 2018
SynAbs inks agreement with SKLM as new distributor for its unique catalogue of monoclonal antibodies in Morocco

Distribution agreement · 17. January 2018
SynAbs inks agreement with Theranostica as new distributor for its unique catalogue of monoclonal antibodies in Israël
Technical breakthrough · 14. December 2017
One-stop-shop solution: from complete CAR-T cell design to anti-CAR-T monoclonal antibodies generation!

Organic growth · 27. November 2017
SynAbs in L'Echo: from UCL to Singapore, a success story in monoclonal antibodies field
Congress · 20. November 2017
SynAbs attended Medica congress in Germany to meet In-Vitro Diagnostic players for monoclonal antibodies discussions

Show more